Patent details

Basic Information

Publication number:

EP2727921

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141532580

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 2

French Title of Invention:

Forme cristalline 2 du 2-((r)-2-méthylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

German Title of Invention:

Kristalline Form 2 von 2-((r)-2-Methylpyrrolidin-2-yl)-1h-Benzimidazol-4-Carbonsäureamid

SPC Number:

Dates

Filing date:

10/10/2008

Grant date:

19/04/2017

EP Publication Date:

07/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/04/2017

EP B1 Publication Date:

19/04/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/10/2017

Expiration date:

10/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/04/2017

 

 

Name:

AbbVie Ireland Unlimited Company

Address:

70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

Inventor

Name:

Zhu, Guidong

Address:

United States (US)

Priority

Priority Number:

979654 P

Priority Date:

12/10/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4184; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

Issue number:

201716

Publication date:

19/04/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2018	Outgoing Correspondence	1